European Patent Office

T 2116/22 (Process for making hemostatic compositions/BAXTER) vom 18.12.2024

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2024:T211622.20241218
Datum der Entscheidung
18. Dezember 2024
Aktenzeichen
T 2116/22
Antrag auf Überprüfung von
-
Anmeldenummer
11724603.3
Verfahrenssprache
Englisch
Verteilung
Nicht verteilt (D)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
Zusammenfassung von Article 084 EPC
Bezeichnung der Anmeldung
PROCESS FOR MAKING DRY AND STABLE HEMOSTATIC COMPOSITIONS
Name des Antragstellers
Baxter International Inc
Baxter Healthcare SA
Name des Einsprechenden
Ferrosan Medical Devices A/S
Ethicon Inc.
Kammer
3.3.07
Leitsatz
-
Relevante Rechtsnormen
European Patent Convention Art 113(1)European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 84European Patent Convention R 106Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)
Schlagwörter
Novelty - main request and auxiliary requests 1-7 (no)
Novelty - auxiliary request 8 (yes)
Stay of the proceedings (no)
Obligation to raise objections - objection dismissed
Late-filed request - auxiliary request 8
Late-filed request - admitted (yes)
Amendments - auxiliary request 8
Amendments - allowable (yes)
Claims - clarity
Claims - auxiliary request 8 (yes)
Inventive step - auxiliary request 8 (yes)
Orientierungssatz
-
Zitierende Akten
T 2263/22

Order

For these reasons it is decided that:

The decision under appeal is set aside.

The case is remitted to the opposition division with the order to maintain the patent on the basis of the claims of auxiliary request 8 filed on 31 March 2023 and a description to be adapted thereto if necessary.

The objection under Rule 106 EPC is dismissed.